| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |